Sarcoidosis: Clinical presentation, diagnosis, and approach to treatment

American Journal of the Medical Sciences

Volumn 335, Issue 1, 2008, Pages 26-33

  Judson, Marc A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Corticosteroids; Diagnosis; Pulmonary; Sarcoidosis; Treatment

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BRONCHODILATING AGENT; CHLOROQUINE; CYCLOPHOSPHAMIDE; DOXYCYCLINE; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PENTOXIFYLLINE; PREDNISONE; THALIDOMIDE;

CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG WITHDRAWAL; EYE DISEASE; HEART DISEASE; HISTOPATHOLOGY; HUMAN; LIVER FUNCTION TEST; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; NEUROLOGIC DISEASE; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; SKIN DEFECT; THORAX RADIOGRAPHY;

EID: 38349014655     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31815d8276     Document Type: Article

References (39)

1. Lynch JP III, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997;18:755-785.
2. Pietinalho A, Ohmichi M, Hirasawa M, et al. Familial sarcoidosis in Finland and Hokkaido, Japan: a comparative study. Respir Med 1999;93:408-412.
3. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52:525-533.
4. Huang CT, Heurich AE, Sutton AL, et al. Mortality in sarcoidosis: a changing pattern of the causes of death. Eur J Respir Dis 1981;62:231-238.
5. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 2001;120:109-114.
6. Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006;129:1246-1252.
7. Shorr AF, Helman DL, Davies DB, et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;25:783-788.
8. Judson MA, Ghent S, Close TP. Sarcoidosis manifested as peripheral pulmonary infiltrates. AJR Am J Roentgenol 1993;160:1359-1360.
9. Reich JM, Brouns MC, O'Connor EA, et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 1998;113:147-153.
10. Highland KB, Retalis P, Coppage L, et al. Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis? South Med J 1997;90:911-914.
11. Sones M, Israel HL. Course and prognosis of sarcoidosis. Am J Med 1960;29:84-93.
12. Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994;61:219-225.
13. Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973;78:65-71.
14. Dawson WB, Muller NL. High-resolution computed tomography in pulmonary sarcoidosis. Semin Ultrasound CT MR 1990;11:423-429.
15. Nishimura K, Itoh H, Kitaichi M, et al. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology 1993;189:105-109.
16. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173.
17. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest 1980;78:640-647.
18. Baydur A, Alsalek M, Louie SG, et al. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest 2001;120:102-108.
19. Bergin CJ, Bell DY, Coblentz CL, et al. Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 1989;171:619-624.
20. Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003;124:922-928.
21. Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 2007;28:83-101.
22. Marshall R, Theirs B, Judson MA, eds. Sarcoidosis. 7th ed. New York: McGraw-Hill.
23. Eklund A, Rizzato G. Skin manifestations in sarcoidosis. Eur Respir J Monogr 2005;10:150-163.
24. Judson MA, Baughman RP. Sarcoidosis. London: Arnold Publishers; 2004.
25. Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 2003;97:978-982.
26. Ohara K, Judson MA, Baughman RP. Clinical aspects of ocular sarcoidosis. Eur Respir J Monogr 2005;10:188-209.
27. Bradley DA, Baughman RP, Raymond L, et al. Ocular manifestations of sarcoidosis. Semin Respir Crit Care Med 2002;23:543-548.
28. Rothova A, Alberts C, Glasius E, et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989;72:287-296.
29. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986;102:297-301.
30. Mayers M. Ocular sarcoidosis. Int Ophthalmol Clin 1990;30:257-263.
31. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253-258.
32. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathological study of 84 unselected patients with systemic sarcoidosis. . Circulation 1978;58:1204-1211.
33. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006-1010.
34. Boglioli LR, Taff ML, Funke S, et al. Sudden death due to sarcoid heart disease. J Forensic Sci 1998;43:1072-1073.
35. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.
36. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004;83:315-334.
37. Chin BB, Civelek AC, Mudun A. Resting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis. Clin Nucl Med 1997;22:475-478.
38. Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest 2004;126:1372-1376.
39. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122:1895-1901.